IACR Newsflash
New guidelines on staging of paediatric cancers
New Paediatric Non-Stage Prognosticator Guidelines & an update of 2014 Toronto Stage Guidelines by the International Agency for Research on Cancer (IARC) & partners have been published.
The guidelines were developed by a panel of international experts and stakeholders during a meeting held at IARC, covering the collection of standardized information, which facilitates the interpretation and comparison of data on survival and mortality across regions and over time. The panel also reviewed and updated the 2014 Toronto Paediatric Cancer Stage Guidelines.
Read the article in the Lancet Oncology here: Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines
Cancer registry news on Twitter
If you are on Twitter, follow GICR @ IARC for the latest on cancer registration, cancer data and cancer control activities and updates around the world
For our cancer registry members and colleagues: contact us if you would like us to share your publications, research and activities on this website, our mailing list and on twitter.
COVID-19 and Cancer Registries Survey
IARC, GICR and IACR is currently inviting cancer registries to respond to an online survey to assess the impact of the COVID-19 pandemic on cancer registration. The survey is being sent by email to registries and is likewise available here: https://is.gd/IACR_GICR_Survey1
PDF copies of survey translations in French, Spanish and Portugese are available for download here:
Encuesta de registros de cáncer IARC-IACR-GICR - español
Enquête IARC-IACR-GICR sur les registres du cancer - français
​Pesquisa sobre registros de câncer da IARC-IACR-GICR- Português
The survey is in support of the COVID-19 and Cancer Task Force to help coordinate efforts to synthesize and rapidly disseminate data on how the coronavirus disease (COVID-19) pandemic is affecting cancer outcomes worldwide.
The deadline for completing the survey has been extended to 22nd May 2020.
Results Overview of the Cancer Registries and COVID-19 Survey
In mid-May, the COVID-19 and Cancer Task Force, through IACR and GICR, reached out to cancer registries with a survey to assess the impact of the COVID-19 pandemic on cancer registration. A total of 218 cancer registries from 90 countries participated in this survey. We therefore extend our most sincere thank you to each registry for taking the time to provide feedback on how the COVID-19 pandemic has impacted their respective cancer registry operations.
We are pleased to share an overview of the survey results:
Two out of three cancer registries indicated their operations, including staff performance and funding, were disrupted due to the pandemic.
For 71% of registries, staff attendance was affected by the pandemic.
We will provide the detailed results from this survey very soon – please stay tuned!
Again, thank you to all our colleagues for helping us assess the impact of COVID-19 on cancer registration. The information, comments and suggestions you shared will help all those in the Task Force, IARC, GICR and IACR in particular, gather and provide targeted support for registry activities in the near future.
ICCR Datasets
Following a period of consultation with the membership and officers of the Board, IACR is endorsing the use of the International Collaboration on Cancer Reporting (ICCR) pathology datasets for cancer reporting.
The links to the datasets are published on IACR's website under: Support for Registries
The published data sets (some of which have translations in Spanish, Portugese and French, are available here: ICCR Datasets
For questions or further information, please ICCR at : This email address is being protected from spambots. You need JavaScript enabled to view it. (T: +61 2 8356 5828)
